This session will address:

• How Pfizer is driving the implementation of flow processes into drug substance manufacture 

• Building modular and the challenges that are currently being overcome and addressed  

• What does the industry standardized approach and landscape look like from a Pfizer perspective? 

• Understanding how to leverage automation integration

• How can strategies be implemented to enhance manufacturing at significantly reduced costs and better quality?

• What future action is Pfizer taking to ensure new facility integration to reduce cycle times further